Stress indices in methadone maintenance treatment - Cross sectional and follow up study.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
09 2020
Historique:
received: 20 03 2020
revised: 07 06 2020
accepted: 07 06 2020
pubmed: 17 6 2020
medline: 23 12 2020
entrez: 17 6 2020
Statut: ppublish

Résumé

To study the prevalence of perceived high stress among methadone maintenance treatment (MMT) patients, and whether stress can predict outcome, and whether stress may improve during treatment, we studied a sample of 107 MMT patients using Perceived Stress Scale (PSS) questionnaires. We studied if PSS scores on admission predict long-term retention, and we monitored stress indices (PSS, heart rate variability, saliva cortisol) on admission, 6 and 12 months later, to measure changes. Variables included demographic data, history of adverse events, and urine test. A sample of 79 (73.8%) males and 28 (26.2%) females whose age at opioid use onset was 22.1±7.2 years and age at study onset 50.5±10.8 years was studied for PSS. Both high and very-high PSS patients characterized (logistic regression) as abusing benzodiazepine, and with history of depressive symptoms. The very-high PSS group on admission (n=29) had shorter cumulative retention (1.8 years, 95%%CI 1.2-2.4) compared with 50 others (2.8 years, 95%%CI 2.3-3.3, p=0.03). Monitoring stress indices among 25 patients found that no-benzodiazepine and cocaine use on admission, opioid discontinuation after 6 months, and any substance discontinuation after a year were associated with stress reduction. Conclusion: stress level appears to normalize among MMT patients if no other substance is abused.

Identifiants

pubmed: 32544714
pii: S0165-1781(20)30596-5
doi: 10.1016/j.psychres.2020.113218
pii:
doi:

Substances chimiques

Methadone UC6VBE7V1Z
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113218

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors have no conflict of interest.

Auteurs

Einat Peles (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Dr. Miriam & Sheldon G. Adelson Clinic for Drug Abuse, Treatment & Research Tel Aviv, Sourasky Medical Center, 1 Henrietta Szold St., Tel Aviv 64924, Israel; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. Electronic address: einatp@tlvmc.gov.il.

Elad Malik (E)

Department of Psychiatry, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.

Yuval Altman (Y)

Hypnocore, Petach Tiqva, Israel.

Anda Baharav (A)

Hypnocore, Petach Tiqva, Israel.

Shaul Schreiber (S)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Dr. Miriam & Sheldon G. Adelson Clinic for Drug Abuse, Treatment & Research Tel Aviv, Sourasky Medical Center, 1 Henrietta Szold St., Tel Aviv 64924, Israel; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel; Department of Psychiatry, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.

Anat Sason (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Miriam Adelson (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH